- cafead Jun 28, 2024 at 11:52: AM
via Immune drug developer Alumis has raised $210 million in one of the biotechnology sector’s largest initial public offerings this year.
Still, the IPO announced Thursday comes in below projections Alumis set earlier this week.
article source
Still, the IPO announced Thursday comes in below projections Alumis set earlier this week.
article source